nach oben

Archives of Dermatological Research

Erschienen in:

15.02.2022 | Review

Skin substitutes for the management of mohs micrographic surgery wounds: a systematic review

verfasst von: Kimberly W. Lu, Amor Khachemoune

Erschienen in: Archives of Dermatological Research | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

The data on skin substitute usage for managing Mohs micrographic surgery (MMS) wounds remain limited. This systematic review aimed to provide an overview of skin substitutes employed for MMS reconstruction, summarize clinical characteristics of patients undergoing skin substitute-based repair after MMS, and identify advantages and limitations of skin substitute implementation. A systematic review of Ovid MEDLINE, EMBASE, Cochrane Library, and Web of Science databases, from inception to April 7, 2021, identified all cases of MMS defects repaired using skin substitutes. A total of 687 patients were included. The mean patient age was 70 years (range: 6–98 years). Commonly used skin substitutes were porcine collagen (n = 397), bovine collagen (n = 78), Integra (n = 53), Hyalofill (n = 43), amnion/chorion-derived grafts (n = 40), and allogeneic epidermal-dermal composite grafts (n = 35). Common factors influencing skin substitute selection were cost, healing efficacy, cosmetic outcome, patient comfort, and ease of use. Some articles did not specify patient and wound characteristics. Skin substitute usage in MMS reconstruction is not well-guided. Blinded randomized control trials comparing the efficacy of skin substitutes and traditional repair methods are imperative for establishing evidence-based guidelines on skin substitute usage following MMS.

Nur mit Berechtigung zugänglich

Aggarwal S, Shah CT, Kirzhner M (2018) Modified second stage Hughes tarsoconjunctival reconstruction for lower eyelid defects. Orbit 37(5):335–340. https://doi.org/10.1080/01676830.2017.1423351CrossRef

Ahmed S, Hussein SS, Philp B, Healy C (2006) Use of biologic dressing as a temporary wound dressing in reconstruction of a significant forehead Mohs defect. Dermatol Surg 32(5):765–767. https://doi.org/10.1111/j.1524-4725.2006.32155.xCrossRef

Becker GD, Adams LA, Hackett J (1994) Collagen-assisted healing of facial wounds after Mohs surgery. Laryngoscope 104(10):1267–1270. https://doi.org/10.1288/00005537-199410000-00015CrossRef

Beers PJ, Adgerson CN, Millan SB (2016) Porcine tri-layer wound matrix for the treatment of stage IV pressure ulcers. JAAD Case Rep 2(2):122–124. https://doi.org/10.1016/j.jdcr.2016.01.001CrossRef

Bell E, Ehrlich HP, Sher S, Merrill C, Sarber R, Hull B et al (1981) Development and use of a living skin equivalent. Plast Reconstr Surg 67(3):386–392. https://doi.org/10.1097/00006534-198103000-00024CrossRef

Bello YM, Falabella AF, Eaglstein WH (2001) Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2(5):305–313. https://doi.org/10.2165/00128071-200102050-00005CrossRef

Bittner GC, Cerci FB, Kubo EM, Tolkachjov SN (2021) Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations. An Bras Dermatol. https://doi.org/10.1016/j.abd.2020.10.004CrossRef

Blechman AB, Stevenson ML, Carucci JA (2018) Repair of a large defect involving the nose, cheek, and upper cutaneous lip. Dermatol Surg 44(12):1631–1634. https://doi.org/10.1097/DSS.0000000000001629CrossRef

Boateng JS, Matthews KH, Stevens HN, Eccleston GM (2008) Wound healing dressings and drug delivery systems: a review. J Pharm Sci 97(8):2892–2923. https://doi.org/10.1002/jps.21210CrossRef

10.

Boyce ST, Lalley AL (2018) Tissue engineering of skin and regenerative medicine for wound care. Burns Trauma 6:4. https://doi.org/10.1186/s41038-017-0103-yCrossRef

11.

Carucci JA, Kolenik SA 3rd, Leffell DJ (2002) Human cadaveric allograft for repair of nasal defects after extirpation of Basal cell carcinoma by Mohs micrographic surgery. Dermatol Surg 28(4):340–343. https://doi.org/10.1046/j.1524-4725.2002.01143.xCrossRef

12.

Castellanos G, Bernabe-Garcia A, Moraleda JM, Nicolas FJ (2017) Amniotic membrane application for the healing of chronic wounds and ulcers. Placenta 59:146–153. https://doi.org/10.1016/j.placenta.2017.04.005CrossRef

13.

Chaiyasate K, Oliver LN, Kreitzberg SA, Lyons M, Goldman J, Lu SM et al (2020) Use of pericranial flaps with dermal substitute for scalp reconstruction: a case series. Plast Reconstr Surg Glob Open 8(8):e3011. https://doi.org/10.1097/GOX.0000000000003011CrossRef

14.

Cho SK, Mattke S, Gordon H, Sheridan M, Ennis W (2020) Development of a model to predict healing of chronic wounds within 12 weeks. Adv Wound Care (New Rochelle) 9(9):516–524. https://doi.org/10.1089/wound.2019.1091CrossRef

15.

Chun YS, Verma K (2011) Single-stage full-thickness scalp reconstruction using acellular dermal matrix and skin graft. Eplasty 11:e4

16.

Chung PH, Leong JY, Voelzke BB (2019) Surgical experience with genital and perineal extramammary paget’s disease. Urology 128:90–95. https://doi.org/10.1016/j.urology.2019.03.006CrossRef

17.

Cronin H, Goldstein G (2013) Biologic skin substitutes and their applications in dermatology. Dermatol Surg 39(1 Pt 1):30–34. https://doi.org/10.1111/j.1524-4725.2012.02561.xCrossRef

18.

Cunningham T, Marks M (2014) Vacuum-assisted closure device and skin substitutes for complex Mohs defects. Dermatol Surg 40(Suppl 9):S120–S126. https://doi.org/10.1097/DSS.0000000000000113CrossRef

19.

Custer PL, Maamari RN (2021) Porcine dermal matrix sandwich graft for lower eyelid reconstruction. Orbit 40(2):138–144. https://doi.org/10.1080/01676830.2020.1755316CrossRef

20.

Dai C, Shih S, Khachemoune A (2020) Skin substitutes for acute and chronic wound healing: an updated review. J Dermatolog Treat 31(6):639–648. https://doi.org/10.1080/09546634.2018.1530443CrossRef

21.

Demidova-Rice TN, Hamblin MR, Herman IM (2012) Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care. Adv Skin Wound Care 25(7):304–314. https://doi.org/10.1097/01.ASW.0000416006.55218.d0CrossRef

22.

Dika E, Fanti PA, Patrizi A, Misciali C, Vaccari S, Piraccini BM (2015) Mohs surgery for squamous cell carcinoma of the nail unit: 10 years of experience. Dermatol Surg 41(9):1015–1019. https://doi.org/10.1097/DSS.0000000000000452CrossRef

23.

Ebrahimi A, Ashayeri M, Rasouli HR (2015) Comparison of local flaps and skin grafts to repair cheek skin defects. J Cutan Aesthet Surg 8(2):92–96. https://doi.org/10.4103/0974-2077.158444CrossRef

24.

Echeverria-Garcia B, Serra-Guillen C, Nagore E, Llombart B, Sanmartin O, Requena C et al (2012) The use of a biosynthetic skin substitute in slow Mohs micrographic surgery. Dermatol Surg 38(4):683–689. https://doi.org/10.1111/j.1524-4725.2011.02277.xCrossRef

25.

Euctr ES (2020) Study of an artificial human skin medicine for patients with basal cell carcinoma undergoing reconstructive surgery. http://wwww.hoint/trialsearch/Trial2aspx?TrialID=EUCTR2018-004738-14-ES

26.

Fancher W, Desai S, Peterson A, Tung R (2015) Aggressive squamous cell carcinoma within a burn scar complicated by m. fortuitum infection: combination treatment with antibiotic therapy, mohs surgery, amnion-chorion graft, and low-intensity pulsed dye laser. Dermatol Surg 41(9):1079–1082. https://doi.org/10.1097/DSS.0000000000000407CrossRef

27.

Filitis DC, Fisher J, Samie FH (2018) Reconstruction of a surgical defect in the popliteal fossa: A case report. Int J Surg Case Rep 53:228–230. https://doi.org/10.1016/j.ijscr.2018.10.070CrossRef

28.

Gironi LC, Boggio P, Colombo E (2015) Reconstruction of scalp defects with exposed bone after surgical treatment of basal cell carcinoma: the use of a bilayer matrix wound dressing. Dermatol Ther 28(3):114–117. https://doi.org/10.1111/dth.12193CrossRef

29.

Gohari S, Gambla C, Healey M, Spaulding G, Gordon KB, Swan J et al (2002) Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol Surg 28(12):1107–1114. https://doi.org/10.1046/j.1524-4725.2002.02130.xCrossRef

30.

Guest JF, Weidlich D, Singh H, La Fontaine J, Garrett A, Abularrage CJ, et al (2017) Cost-effectiveness of using adjunctive porcine small intestine submucosa tri-layer matrix compared with standard care in managing diabetic foot ulcers in the US. J Wound Care. 26(Sup1):S12–S24. https://doi.org/10.12968/jowc.2017.26.Sup1.S12

31.

Gupta S, Mohapatra DP, Chittoria RK, Subbarayan E, Reddy SK, Chavan V et al (2019) Human skin allograft: is it a viable option in management of burn patients? J Cutan Aesthet Surg 12(2):132–135. https://doi.org/10.4103/JCAS.JCAS_83_18CrossRef

32.

Halim AS, Khoo TL, Mohd Yussof SJ (2010) Biologic and synthetic skin substitutes: An overview. Indian J Plast Surg 43(Suppl):S23–S28. https://doi.org/10.4103/0970-0358.70712CrossRef

33.

Hansen SL, Voigt DW, Wiebelhaus P, Paul CN (2001) Using skin replacement products to treat burns and wounds. Adv Skin Wound Care 14(1):37–44. https://doi.org/10.1097/00129334-200101000-00016CrossRef

34.

Hessam S, Georgas D, Sand M, Bechara FG (2014) Complete skin resection of the dorsum of the hand: a prophylactic approach using a dermal regeneration template. J Cutan Med Surg 18(1):56–59. https://doi.org/10.2310/7750.2013.13061CrossRef

35.

Horch RE, Jeschke MG, Spilker G, Herndon DN, Kopp J (2005) Treatment of second degree facial burns with allografts–preliminary results. Burns 31(5):597–602. https://doi.org/10.1016/j.burns.2005.01.011CrossRef

36.

Ibrahim AM, Rabie AN, Borud L, Tobias AM, Lee BT, Lin SJ (2014) Common patterns of reconstruction for Mohs defects in the head and neck. J Craniofac Surg 25(1):87–92. https://doi.org/10.1097/SCS.0b013e3182a2e9ebCrossRef

37.

Inhoff O, Faulhaber J, Rothhaar B, Goerdt S, Koenen W (2010) Analysis of treatment costs for complex scalp wounds. J Dtsch Dermatol Ges 8(11):890–896. https://doi.org/10.1111/j.1610-0387.2010.07474.xCrossRef

38.

Kircik LH, Dickerson JE Jr, Kitten C, Weedon KA, Slade HB (2013) Allogeneic growth arrested keratinocytes and fibroblasts delivered in a fibrin spray accelerate healing in Mohs micrographic surgery wounds. J Drugs Dermatol 12(5):558–561

39.

Kirsner RS, Marston WA, Snyder RJ, Lee TD, Cargill DI, Slade HB (2012) Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet 380(9846):977–985. https://doi.org/10.1016/S0140-6736(12)60644-8CrossRef

40.

Kolenik SA III, McGovern TW, Leffell DJ (1999) Use of a lyophilized bovine collagen matrix in postoperative wound healing. Dermatol Surg 25(4):303–307CrossRef

41.

Kolenik SA 3rd, Leffell DJ (1995) The use of cryopreserved human skin allografts in wound healing following Mohs surgery. Dermatol Surg 21(7):615–620. https://doi.org/10.1111/j.1524-4725.1995.tb00517.xCrossRef

42.

Kontos AP, Qian Z, Urato NS, Hassanein A, Proper SA (2009) AlloDerm grafting for large wounds after Mohs micrographic surgery. Dermatol Surg 35(4):692–698. https://doi.org/10.1111/j.1524-4725.2009.01123.xCrossRef

43.

Lee KH (2000) Tissue-engineered human living skin substitutes: development and clinical application. Yonsei Med J 41(6):774–779. https://doi.org/10.3349/ymj.2000.41.6.774CrossRef

44.

Lee SM, Stewart CL, Miller CJ, Chu EY (2015) The histopathologic features of Integra(R) Dermal Regeneration Template. J Cutan Pathol 42(5):368–369. https://doi.org/10.1111/cup.12488CrossRef

45.

Limova M (2010) Active wound coverings: bioengineered skin and dermal substitutes. Surg Clin North Am 90(6):1237–1255. https://doi.org/10.1016/j.suc.2010.08.004CrossRef

46.

Lin MJ, Dubin DP, Khorasani H (2020) Acellular porcine transitional cell matrix xenograft for genital wounds. Dermatol Surg 46(9):1245–1246. https://doi.org/10.1097/DSS.0000000000002096CrossRef

47.

Loeffelbein DJ, Baumann C, Stoeckelhuber M, Hasler R, Mucke T, Steinstrasser L et al (2012) Amniotic membrane as part of a skin substitute for full-thickness wounds: an experimental evaluation in a porcine model. J Biomed Mater Res B Appl Biomater 100(5):1245–1256. https://doi.org/10.1002/jbm.b.32689CrossRef

48.

Lyons AB, Chipps LK, Moy RL, Herrmann JL (2018) Dehydrated human amnion/chorion membrane allograft as an aid for wound healing in patients with full-thickness scalp defects after Mohs micrographic surgery. JAAD Case Rep 4(7):688–691. https://doi.org/10.1016/j.jdcr.2018.03.015CrossRef

49.

Marzolf S, Srivastava D, Nijhawan RI (2018) Porcine xenografts for surgical defects: Experience of a single center with 128 cases. J Am Acad Dermatol 78(5):1005–1007. https://doi.org/10.1016/j.jaad.2017.10.036CrossRef

50.

Mohan R, Bajaj A, Gundappa M (2017) Human amnion membrane: potential applications in oral and periodontal field. J Int Soc Prev Community Dent 7(1):15–21. https://doi.org/10.4103/jispcd.JISPCD_359_16CrossRef

51.

Moustafa M, Bullock AJ, Creagh FM, Heller S, Jeffcoate W, Game F et al (2007) Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers. Regen Med 2(6):887–902. https://doi.org/10.2217/17460751.2.6.887CrossRef

52.

Nathoo R, Howe N, Cohen G (2014) Skin substitutes: an overview of the key players in wound management. J Clin Aesthet Dermatol 7(10):44–48

53.

Nct (2019) Porcine Xenograft Versus Second Intention Healing. https://clinicaltrialsgov/show/NCT03931746

54.

Nct (2020) Enhanced secondary intention healing vs. standard secondary intention healing in mohs surgical defects on the head and distal lower extremities. https://clinicaltrialsgov/show/NCT04545476

55.

Nicoletti G, Tresoldi MM, Malovini A, Visaggio M, Faga A, Scevola S (2018) Versatile use of dermal substitutes: A retrospective survey of 127 consecutive cases. Indian J Plast Surg 51(1):46–53. https://doi.org/10.4103/ijps.IJPS_217_17CrossRef

56.

Nieto-Benito LM, Berenguer-Frohner B, Parra-Blanco V, Campos-Dominguez M (2020) Pigmented dermatofibrosarcoma protuberans: description of a pediatric case. Rev Chil Pediatr 91(1):99–104. https://doi.org/10.32641/rchped.v91i1.1303

57.

Nussbaum SR, Carter MJ, Fife CE, DaVanzo J, Haught R, Nusgart M et al (2018) An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds. Value Health 21(1):27–32. https://doi.org/10.1016/j.jval.2017.07.007CrossRef

58.

Oro-Ayude M, Gonzalez-Sixto B, Feal C, Florez A (2020) Scalp defect reconstruction using a bilayer dermal wound matrix and a split-thickness skin graft. Actas Dermosifiliogr (Engl Ed) 111(2):165–166. https://doi.org/10.1016/j.ad.2018.12.006CrossRef

59.

Pickert AJ, Nemeth Ochoa SA (2013) Use of porcine xenografts on partial-thickness vermilion border and mucosal lower lip Mohs defects. Dermatol Surg 39(6):948–950. https://doi.org/10.1111/dsu.12151CrossRef

60.

Quinby WC Jr, Hoover HC, Scheflan M, Walters PT, Slavin SA, Bondoc CC (1982) Clinical trials of amniotic membranes in burn wound care. Plast Reconstr Surg 70(6):711–717. https://doi.org/10.1097/00006534-198212000-00009CrossRef

61.

Raimer DW, Group AR, Petitt MS, Nosrati N, Yamazaki ML, Davis NA, et al (2011) Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds. Dermatol Online J. 17(9):1

62.

Renner R, Harth W, Simon JC (2009) Transplantation of chronic wounds with epidermal sheets derived from autologous hair follicles–the Leipzig experience. Int Wound J 6(3):226–232. https://doi.org/10.1111/j.1742-481X.2009.00609.xCrossRef

63.

Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6(3):331–343. https://doi.org/10.1016/s0092-8674(75)80001-8CrossRef

64.

Rogge MN, Slutsky JB, Council ML, Fosko SW (2015) Bovine collagen xenograft repair of extensive surgical scalp wounds with exposed calvarium in the elderly: increased rates of wound healing. Dermatol Surg 41(7):794–802. https://doi.org/10.1097/DSS.0000000000000374CrossRef

65.

Roth RR, Winton GB (1989) A synthetic skin substitute as a temporary dressing in Mohs surgery. J Dermatol Surg Oncol 15(6):670–672. https://doi.org/10.1111/j.1524-4725.1989.tb03607.xCrossRef

66.

Schurr MJ, Foster KN, Centanni JM, Comer AR, Wicks A, Gibson AL et al (2009) Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute. J Trauma 66(3):866–873. https://doi.org/10.1097/TA.0b013e31819849d6CrossRef

67.

Sen CK (2019) Human wounds and its burden: an updated compendium of estimates. Adv Wound Care (New Rochelle) 8(2):39–48. https://doi.org/10.1089/wound.2019.0946CrossRef

68.

Shakespeare P, Shakespeare V (2002) Survey: use of skin substitute materials in UK burn treatment centres. Burns 28(4):295–297. https://doi.org/10.1016/s0305-4179(02)00062-1CrossRef

69.

Sleiwah A, Psomadakis C, Craythorne E, Stefanato CM, Rickaby W, Robson A et al (2021) Dermatofibrosarcoma protuberans (DFSP) in children: A combined multidisciplinary approach. Pediatr Dermatol 38(1):233–236. https://doi.org/10.1111/pde.14425CrossRef

70.

Snyder D, Sullivan N, Margolis D, Schoelles K (2020) Skin Substitutes for Treating Chronic Wounds. AHRQ Technology Assessments, Rockville

71.

Stebbins WG, Hanke CW, Petersen J (2011) Human cadaveric dermal matrix for management of challenging surgical defects on the scalp. Dermatol Surg 37(3):301–310. https://doi.org/10.1111/j.1524-4725.2011.01877.xCrossRef

72.

Tarlow MM, Nossa R, Spencer JM (2001) Effective management of difficult surgical defects using tissue-engineered skin. Dermatol Surg 27(1):71–74

73.

Taylor O, Li JN, Carr C, Garcia A, Tran S, Srivastava D et al (2020) The effect of antibiotic prophylaxis on infection rates in mohs micrographic surgery: a single-institution retrospective study. Arch Dermatol Res. https://doi.org/10.1007/s00403-020-02153-3CrossRef

74.

Tognetti L, Pianigiani E, Ierardi F, Lorenzini G, Casella D, Liso FG et al (2021) The use of human acellular dermal matrices in advanced wound healing and surgical procedures: State of the art. Dermatol Ther 34(4):e14987. https://doi.org/10.1111/dth.14987CrossRef

75.

Tottoli EM, Dorati R, Genta I, Chiesa E, Pisani S, Conti B (2020) Skin wound healing process and new emerging technologies for skin wound care and regeneration. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12080735CrossRef

76.

Trent JF, Kirsner RS (1998) Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Int J Clin Pract 52(6):408–413

77.

Unal S, Ersoz G, Demirkan F, Arslan E, Tutuncu N, Sari A (2005) Analysis of skin-graft loss due to infection: infection-related graft loss. Ann Plast Surg 55(1):102–106. https://doi.org/10.1097/01.sap.0000164531.23770.60CrossRef

78.

van der Veen VC, van der Wal MB, van Leeuwen MC, Ulrich MM, Middelkoop E (2010) Biological background of dermal substitutes. Burns 36(3):305–321. https://doi.org/10.1016/j.burns.2009.07.012CrossRef

79.

Vig K, Chaudhari A, Tripathi S, Dixit S, Sahu R, Pillai S et al (2017) Advances in Skin Regeneration Using Tissue Engineering. Int J Mol Sci. https://doi.org/10.3390/ijms18040789CrossRef

80.

Vyas KS, Vasconez HC (2014) Wound healing: biologics, skin substitutes, Biomembranes and Scaffolds. Healthcare (Basel) 2(3):356–400. https://doi.org/10.3390/healthcare2030356CrossRef

81.

Wanitphakdeedecha R, Chen TM, Nguyen TH (2008) The use of acellular, fetal bovine dermal matrix for acute, full-thickness wounds. J Drugs Dermatol 7(8):781–784

82.

Waymack P, Duff RG, Sabolinski M (2000) The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds The Apligraf Burn Study Group. Burns 26(7):609–619. https://doi.org/10.1016/s0305-4179(00)00017-6CrossRef

83.

Wetzig T, Gebhardt C, Simon JC (2009) New indications for artificial collagen-elastin matrices? Covering exposed tendons. Dermatology 219(3):272–273. https://doi.org/10.1159/000232387CrossRef

84.

Wisco OJ (2016) Case series: The use of a dehydrated human amnion/chorion membrane allograft to enhance healing in the repair of lower eyelid defects after Mohs micrographic surgery. JAAD Case Rep 2(4):294–297. https://doi.org/10.1016/j.jdcr.2016.06.002CrossRef

85.

Yang YW, Ochoa SA (2016) Use of porcine xenografts in dermatology surgery: the mayo clinic experience. Dermatol Surg 42(8):985–991. https://doi.org/10.1097/DSS.0000000000000804CrossRef

86.

Yeh DD, Nazarian RM, Demetri L, Mesar T, Dijkink S, Larentzakis A et al (2017) Histopathological assessment of OASIS Ultra on critical-sized wound healing: a pilot study. J Cutan Pathol 44(6):523–529. https://doi.org/10.1111/cup.12925CrossRef

87.

Zalla MJ, Campbell E (2019) The use of human amnion/chorion membrane and umbilical cord grafts for treatment of a scalp wound with exposed bone. Dermatol Surg 45(9):1200–1203. https://doi.org/10.1097/DSS.0000000000001705CrossRef

Titel: Skin substitutes for the management of mohs micrographic surgery wounds: a systematic review
verfasst von: Kimberly W. Lu
Amor Khachemoune
Publikationsdatum: 15.02.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Dermatological Research / Ausgabe 1/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-022-02327-1

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Reappraisal and literature review of primary cutaneous cribriform apocrine carcinoma

Diagnostic work-up and treatment in patients with pyoderma gangrenosum: retrospective analysis of US insurance claims-based data

Impact of COVID-19 on dermatologic surgery: experience of a Midwestern academic practice

Comparison of vascular endothelial growth factor expression between lesional and non-lesional skin in patients with morphea: a dermoscopy-guided immunohistochemical study

Factors affecting outcomes of second intent healing of nasal defects after Mohs micrographic surgery